Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
made a significant entry into the Indian pharmaceutical market by launching Lirafit, a biosimilar of the widely used anti-diabetic drug liraglutide
Peptide-Protein Interaction Research IGF-1 LR3 supports investigations into interactions with binding proteins such as IGFBPs
Licensed weight-management medicines currently available in the UK include: Semaglutide (Wegovy) approved by the MHRA for chronic weight management in adults with a BMI of 30 kg/m or above, or 27 kg/m or above with at least one weight-related comorbidity
Journal of Applied Genetics
Taylor, A
US$ 22.98
US$ 24.90
US$ 20.78
